1. Home
  2. MRUS vs LOPE Comparison

MRUS vs LOPE Comparison

Compare MRUS & LOPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • LOPE
  • Stock Information
  • Founded
  • MRUS 2003
  • LOPE 1949
  • Country
  • MRUS Netherlands
  • LOPE United States
  • Employees
  • MRUS N/A
  • LOPE N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • LOPE Other Consumer Services
  • Sector
  • MRUS Health Care
  • LOPE Real Estate
  • Exchange
  • MRUS Nasdaq
  • LOPE Nasdaq
  • Market Cap
  • MRUS 3.6B
  • LOPE 4.0B
  • IPO Year
  • MRUS 2016
  • LOPE 2008
  • Fundamental
  • Price
  • MRUS $46.58
  • LOPE $159.98
  • Analyst Decision
  • MRUS Strong Buy
  • LOPE Buy
  • Analyst Count
  • MRUS 10
  • LOPE 3
  • Target Price
  • MRUS $86.70
  • LOPE $179.67
  • AVG Volume (30 Days)
  • MRUS 376.4K
  • LOPE 232.6K
  • Earning Date
  • MRUS 10-31-2024
  • LOPE 11-06-2024
  • Dividend Yield
  • MRUS N/A
  • LOPE N/A
  • EPS Growth
  • MRUS N/A
  • LOPE 18.90
  • EPS
  • MRUS N/A
  • LOPE 7.64
  • Revenue
  • MRUS $35,932,000.00
  • LOPE $1,018,713,000.00
  • Revenue This Year
  • MRUS N/A
  • LOPE N/A
  • Revenue Next Year
  • MRUS $52.49
  • LOPE $17.52
  • P/E Ratio
  • MRUS N/A
  • LOPE $20.90
  • Revenue Growth
  • MRUS N/A
  • LOPE 8.22
  • 52 Week Low
  • MRUS $22.26
  • LOPE $118.48
  • 52 Week High
  • MRUS $61.61
  • LOPE $173.37
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 32.37
  • LOPE 68.51
  • Support Level
  • MRUS $48.42
  • LOPE $135.32
  • Resistance Level
  • MRUS $53.49
  • LOPE $173.37
  • Average True Range (ATR)
  • MRUS 2.17
  • LOPE 5.60
  • MACD
  • MRUS -0.54
  • LOPE 2.38
  • Stochastic Oscillator
  • MRUS 5.73
  • LOPE 74.78

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About LOPE Grand Canyon Education Inc.

Grand Canyon Education, Inc is a publicly traded education services company dedicated to serving colleges and universities. GCE's most significant university partner is Grand Canyon University, an Arizona non-profit corporation that operates a comprehensive regionally accredited university that offers graduate and undergraduate degree programs, emphases and certificates across nine colleges both online, on ground at its campus in Phoenix, Arizona and at four off-site classroom and laboratory sites. The Company generates all of its revenue through services agreements with its university partners.

Share on Social Networks: